TAKEDA PHARMACEUTICAL CO LTD·4

Apr 28, 6:04 AM ET

Kim Julie So-Young 4

Research Summary

AI-generated summary

Updated

Takeda (TAK) CEO‑Elect Kim Julie So‑Young Receives 105,416 RSU Award

What Happened Kim Julie So‑Young, Takeda’s CEO‑Elect, was granted 105,416 restricted stock units (RSUs) reported as an award (transaction code A) on a Form 4 with a transaction date of 2026-04-27 and filed 2026-04-28. The reported grant price is $0.00, so no cash was paid for the award; total reported value on the Form 4 is $0. The award was determined by the Compensation Committee based on performance metrics (core revenue, core operating profit, and R&D milestones).

Key Details

  • Transaction date: 2026-04-27; Form 4 filed: 2026-04-28 (timely).
  • Reported grant: 105,416 RSUs @ $0.00 (transaction code A — award/grant).
  • Shares/units reported after transaction: filing notes 256,372 RSUs (each RSU = 1 American Depositary Share).
  • Vesting schedule (per footnote): July 1, 2026 — 175,526 shares; July 1, 2027 — 52,218 shares; July 1, 2028 — 28,628 shares (total 256,372).
  • Footnote: RSUs originate from a July 1, 2023 award tied to specified performance metrics; the Committee set the award amount on April 27, 2026.

Context

  • This is an award/grant (not a purchase or sale); awards are compensation and do not directly signal a purchase decision by the insider.
  • RSUs are contingent rights to receive ADSs upon vesting and may be subject to forfeiture if performance/vesting conditions are not met.
  • Filing appears timely (no late-filing flag).